Graves' Disease (Overactive Thyroid) Market– Global Industry Trends & Forecast to 2029
Graves'
Disease (Overactive Thyroid) Market is expected to gain market growth in the forecast period of
2021 to 2029. Data Bridge Market Research analyses that the Graves' disease
(overactive thyroid) market was valued at USD 351.55 million in 2021 and is
expected to reach USD 507.65 million by 2029, registering a CAGR of 4.70%
during the forecast period of 2022 to 2029
The Graves'
Disease (Overactive Thyroid) Market Scope and Size
Market Definition
Graves' disease (overactive thyroid),
sometimes known as Basedow's disease, is an autoimmune condition that leads to
hyperthyroidism. It occurs when the body's immune cells attack the thyroid,
causing excessive thyroid hormone production. Graves' disease treatment aims to
inhibit thyroid hormone production and block the hormones' effects on the body.
Beta-blockers including propranolol and metoprolol are frequently used as first-line
treatments. These medications help to keep your heart rate in check and
safeguard it until other hyperthyroidism treatments take effect. Market
Segmentation
The Graves' disease (overactive thyroid)
market is segmented on the basis of treatment, diagnosis, route of administration,
end-users and distribution channel. The growth amongst these segments will help
you analyze meagre growth segments in the industries and provide the users with
a valuable market overview and market insights to help them make strategic
decisions for identifying core market applications.
Treatment
·
Radioactive iodine therapy
·
Medication
·
Corticosteroids
·
Beta blockers
·
Propranolol
·
Atenolol
·
Metoprolol
·
Nadolol
Anti-thyroid
medications
·
Propylthiouracil
·
Methimazole
·
Others
Diagnosis
·
Radioactive Iodine Uptake
·
Imaging Tests
·
CT scan
·
Ultrasound
·
Magnetic resonance imaging (MRI)
·
Others
·
Blood Tests
·
Others
Route of
Administration
·
Oral
·
Parenteral
·
Others
End-Users
·
Hospitals
·
Specialty Clinics
·
Homecare
·
Others
Distribution
Channel
·
Hospital Pharmacy
·
Retail Pharmacy
·
Online Pharmacy
·
Others
Get the
sample copy of Report here : https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-graves-disease-overactive-thyroid-market
Market Analysis and Insights - Graves' Disease (Overactive
Thyroid) Market
The Graves' disease
(overactive thyroid) market is analysed and market size insights and trends are
provided by country, treatment, diagnosis, route of administration, end-users
and distribution channel as referenced above.
North America dominates the
Graves' disease (overactive thyroid) market because of the rising prevalence of
Graves' disease (overactive thyroid) and technological advancement in the
treatment in this region. Additionally, rising healthcare expenditure and the
presence of major key players will further propel the market's growth rate.
Graves' Disease (Overactive
Thyroid) Market Country
Level Analysis
The countries covered in the
Graves' disease (overactive thyroid) market report are U.S., Canada and Mexico
in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium,
Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India,
South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines,
Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E,
South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of
Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as
part of South America
Graves' Disease (Overactive Thyroid) Market Share Analysis
The Graves' disease
(overactive thyroid) market competitive landscape provides details by
competitor. Details included are company overview, company financials, revenue
generated, market potential, investment in research and development, new market
initiatives, global presence, production sites and facilities, production
capacities, company strengths and weaknesses, product launch, product width and
breadth, application dominance. The above data points provided are only related
to the companies' focus related to Graves' disease (overactive thyroid) market
Key Players Graves' Disease (Overactive Thyroid) Market
·
F. Hoffmann-La Roche Ltd.
(Switzerland)
·
Mylan N.V. (U.S.)
·
Teva Pharmaceutical
Industries Ltd. (Ireland)
·
Sanofi (France)
·
Pfizer Inc. (U.S.)
·
GlaxoSmithKline plc (U.K.)
·
Novartis AG (Switzerland)
·
Merck & Co., Inc. (U.S.)
·
Allergan (Ireland)
Get Full
Access of Report: https://www.databridgemarketresearch.com/reports/global-graves-disease-overactive-thyroid-market
MAJOR TOC
OF THE REPORT
Chapter One: Introduction
Chapter Two: Market Segmentation
Chapter Three: Market Overview
Chapter Four: Executive Summary
Chapter Five: Premium Insights
Chapter Six: Global Graves' Disease
(Overactive Thyroid) Market by Product & Procedure type
Get TOC
Details: https://www.databridgemarketresearch.com/toc/?dbmr=global-graves-disease-overactive-thyroid-market
Browse
Related Reports@
Thyroid
Cancer Diagnostics Market
About Us:
Data
Bridge Market Research set forth itself as an
unconventional and neoteric Market research and consulting firm with
unparalleled level of resilience and integrated approaches. We are determined
to unearth the best market opportunities and foster efficient information for
your business to thrive in the market
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818

Comments
Post a Comment